PT  - JOURNAL ARTICLE
AU  - K Nakagome
AU  - M Dohi
AU  - K Okunishi
AU  - R Tanaka
AU  - J Miyazaki
AU  - K Yamamoto
TI  - In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-β in the lung
AID  - 10.1136/thx.2005.056317
DP  - 2006 Oct 01
TA  - Thorax
PG  - 886--894
VI  - 61
IP  - 10
4099  - http://thorax.bmj.com/content/61/10/886.short
4100  - http://thorax.bmj.com/content/61/10/886.full
SO  - Thorax2006 Oct 01; 61
AB  - Backgroud: Idiopathic pulmonary fibrosis is a devastating disorder for which there is no effective treatment. Transforming growth factor (TGF)-β plays a critical role in provoking fibrosis. Interleukin (IL)-10 is a potent immunosuppressive cytokine but its effect on the fibrosing process is unclear. A study was undertaken to examine whether IL-10 affects the production and activation of TGF-β and thus can attenuate the fibrosis.Methods: Mice were given an intratracheal injection of bleomycin. On day 1 or 14, IL-10 gene was delivered by rapid intravenous injection of Ringer’s solution containing plasmid. Two weeks after the plasmid injection the mice were examined for fibrosis. The effect of IL-10 on TGF-β production by alveolar macrophages was assessed.Results: Even when delivered during the fibrosing phase, IL-10 gene significantly suppressed the pathological findings, hydroxyproline content, and production of both active and total forms of TGF-β1 in the lung. Immunohistochemical analyses showed that alveolar macrophages were one of the major sources of TGF-β1 and IL-10 diminished the intensity of the staining. IL-10 also suppressed the expression of αVβ6 integrin, a molecule that plays an important role in TGF-β activation, on lung epithelial cells. Alveolar macrophages from bleomycin injected mice produced TGF-β1 spontaneously ex vivo, which was significantly suppressed by treatment of the mice in vivo or by treatment of the explanted macrophages ex vivo with IL-10.Conclusion: IL-10 suppresses the production and activation of TGF-β in the lung and thus attenuates pulmonary fibrosis, even when delivered in the chronic phase.